Breast cancer screening programs are under growing pressure: patient volumes are rising, radiology departments face staffing shortages, and patients expect ...
Operational excellence is a quality strategy from a clinical standpoint as well as a financial initiative to maintain a medical group's sustainability, this new CMO says.
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...
Launched in 2023 and expanded nationally in 2024, the program combined Amalgam's clinical decision support and population health workflows with Exact Sciences' Cologuard® test as a noninvasive ...
The UK's first comprehensive evaluation of the use of Artificial Intelligence (AI) in breast cancer screening found that it can increase breast cancer detection by 10.4% and has the potential to ...
Since its peak in 1991, the cancer death rate has dropped 34%, averting an estimated 4.5 million deaths due, in part, to earlier detection of the most common types of cancer. Screening tests are ...
Although considered a single class, fecal immunochemical tests (FITs) vary in their ability to detect advanced colorectal neoplasia (ACN) and should not be considered interchangeable, new research ...
Cancer screening is at a turning point. For decades, most tests focused on one form of the disease — like mammograms for breast cancer or colonoscopies for colorectal cancer — but new advances have ...
Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...
Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,000 1 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...
SPRINGFIELD, Mo. (KY3) - Mercy is offering a new, revolutionary cancer screening that can detect around fifty types of cancer even earlier with a simple blood test. It’s called Multi-Cancer Early ...
Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results